Acp-103-045
ClinicalTrials.gov NCT03325556
Research payments
$2,284,427
Through program year 2020, $2,284,427 in research payments was reported against Acp-103-045, across 257 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03325556
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $498,123 | 59 |
| 2019 | Research | $1,786,304 | 198 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Hernandez Hialeah, FL Named on 20 payments
- Heber Varela Miami, FL Named on 16 payments
- Ashok Patel Toms River, NJ Named on 15 payments
- Shanker Dixit Las Vegas, NV Named on 14 payments
- Franco Sicuro Olivette, MO Named on 12 payments
- Mark Dibuono Staten Island, NY Named on 12 payments
- Ira Goodman Orlando, FL Named on 11 payments
- Victor Faradji Miami, FL Named on 11 payments
- Vibhash Sharma Atlanta, GA Named on 11 payments
- Danesh Alam Westmont, IL Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.